Development of Cloned Porcine Embryos from Donor Cells Treated with 5-Aza-2'-deoxyctidine with or Without Addition of Trichostatin A.
Yun Fei Diao,Rong Xun Han,Hong Rye Kim,Jin Yu Zhang,Park Chang Sik,Dong Il Jin
DOI: https://doi.org/10.1093/biolreprod/85.s1.247
2011-01-01
Biology of Reproduction
Abstract:5-aza-2′-deoxycytidine (5-aza-dC) is a DNA methyltransferase inhibitor that lowers the level of DNA methylation in cells and embryos. Trichostatin A (TSA) is a histone deacetylase inhibitor that increases the extent of histone acetylation in cells and embryos. The objective of the present study was to investigate the effects of treating donor porcine fetal fibroblast cells with 5-aza-dC, with or without TSA, on the development of porcine nuclear transfer (NT) embryos. The project was divided into three parts. Experiment 1 evaluated the effects of exposure of donor cells to 5-aza-dC, for various times, on development of NT embryos. Growing donor cells (at about 50% confluence) were treated with 5 nM 5-aza-dC for various times (0, 1, 6, or 20 h) and the methylation status of PRE-1 clusters was analyzed by bisulfite sequencing. Also, the development of reconstructed embryos was explored. The extent of methylation of PRE-1 sequences gradually decreased in cells treated with 5-aza-dC for longer exposure times (the values were 55%, 51%, 43%, and 41% at 0, 1, 6, and 20 h of treatment, respectively). However, NT embryos did not improve blastocyst development rate when donor cells were treated with 5-aza-dC for longer times (13.4%, 18.8%, 19%, and 16.9% for 0, 1, 6, and 20 h of treatment, respectively). Experiment 2 evaluated the effects of donor cell exposure to different concentrations of 5-aza-dC on development of NT embryos. Growing donor cells were treated with different concentrations (0 nM, 5 nM, 10 nM, or 50 nM) of 5-aza-dC for 1 h before NT. The blastocyst development rate of reconstructed embryos formed using donor cells treated with 5 nM 5-aza-dC was greater (16%) than that observed when the drug was employed at higher concentrations. The levels in the 0 nM, 10 nM and 50 nM groups were 11.7%, 15.7%, and 11.6% respectively. Experiment 3 evaluated whether treatment of donor cells with both 5-aza-dC and TSA improved development of NT embryos. Donor cells were treated with 5 nM 5-aza-dC for 1 h and next exposed to 50 nM TSA, also for 1 h. When donor cells thus treated were tested, the blastocyst development rate of reconstructed embryos was no higher than that of control cells (12.3% vs. 11.8%, p>0.05). When drug concentrations were reduced to 2.5 nM 5-aza-dC and 25 nM TSA, the blastocyst development rate of reconstructed embryos increased significantly, compared with the control group (25.3% vs. 11.8%, p<0.05). The data indicate that a 1 h exposure of donor cells to 5 nM 5-aza-dC facilitated NT embryo development. Further, low-level combination treatment with 5-aza-dC and TSA may improve development of NT embryos.